Featured Stories in the News
There are currently no news releases.
Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
DateTitle 
11/30/17BioTelemetry, Inc. Enters Agreement to Provide Cardiac Monitoring for Apple’s Heart Study
MALVERN, Pa., Nov. 30, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading mobile and wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today a partnership with Apple (NASDAQ:AAPL) to provide cardiac monitoring services in conjunction with the Apple Heart Study.  The study, which launched today, is expected to discover undiagnosed irregular heart rhythms, such as atrial fibrillation... 
Printer Friendly Version
11/27/17Telcare, a Division of BioTelemetry, Inc., Announces Collaboration with Onduo in Diabetes Management Program
MALVERN, Pa., Nov. 27, 2017 (GLOBE NEWSWIRE) -- (NASDAQ:BEAT) – Telcare, the manufacturer of the world’s first FDA-cleared cellular-enabled blood glucose monitor, has entered into a strategic collaboration with Onduo, a joint venture created by Verily (an Alphabet company) and Sanofi.  Under this partnership, Telcare will serve as the supplier of remote blood glucose systems and the resulting data for patients enrolled in Onduo’s groundbreaking diabetes management program. Onduo will leverage... 
Printer Friendly Version
11/07/17BioTelemetry, Inc. Reports Third Quarter 2017 Financial Results
Company Posts Strong Growth with Integration Ahead of Schedule  Reports Record Quarterly Revenue and Adjusted EBITDA MALVERN, Pa., Nov. 07, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading mobile and wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the third quarter ended September 30, 2017. Company Highlights Recognized highest quarterly revenue in Co... 
Printer Friendly Version
10/30/17BioTelemetry, Inc. to Release Third Quarter 2017 Earnings Results on November 7, 2017
MALVERN, Pa., Oct. 30, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its third quarter 2017 earnings on Tuesday, November 7th at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Tuesday, November 7, 2017.  The broadcast will be available through the investor information section of the BioTelemetry website www.gobio.com.  If you are unable to participate during the live webcast, an archive will be available on our... 
Printer Friendly Version
10/25/17BioTelemetry Research and AMRA Raise the Standard for Medical Imaging in NASH/NAFLD Clinical Trials
First to Market Alliance Increases Precision and Specificity while Reducing Cost MALVERN, Pa., Oct. 25, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced that BioTelemetry Research, their leading global imaging and cardiac core lab, and AMRA, the international leader in body composition analysis, have formed an exclusive alliance ... 
Printer Friendly Version
08/08/17BioTelemetry, Inc. Reports Second Quarter 2017 Financial Results
Reports Record Quarterly Revenue and EBITDA   Raises Full Year 2017 Guidance MALVERN, Pa., Aug. 08, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the second quarter ended June 30, 2017. Company Highlights Recognized highest quarterly revenue in Company’s history of $58.1 million, a 10.3% increase over... 
Printer Friendly Version
07/31/17BioTelemetry, Inc. to Release Second Quarter 2017 Earnings Results on August 8, 2017
MALVERN, Pa., July 31, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its second quarter 2017 earnings on Tuesday, August 8 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Tuesday, August 8, 2017.  The broadcast will be available through the investor information section of the BioTelemetry website www.gobio.com.  If you are unable to participate during the live webcast, an archive will be available on our webs... 
Printer Friendly Version
07/12/17BioTelemetry, Inc. Completes LifeWatch AG Acquisition
Deal Solidifies BioTelemetry’s Leadership Position in Remote Cardiac Monitoring MALVERN, Pa. and ZUG, Switzerland, July 12, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the world’s leading wireless medical technology company focused on the delivery of health information for healthcare providers to monitor and diagnose patients accurately and cost-effectively, announces it has completed its acquisition of LifeWatch AG (SIX:LIFE).  “We are gratified that LifeWatch AG shareholde... 
Printer Friendly Version
07/07/17BioTelemetry, Inc. Reaches a Final Milestone in Acquisition of LifeWatch AG
MALVERN, Pa. and ZUG, Switzerland, July 07, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today the definitive results of the tender offer for LifeWatch AG (SIX:LIFE) which concluded on June 28, 2017.  The definitive results show shareholders have tendered 17,848,661 shares of LifeWatch, representing approximately 97% of the to... 
Printer Friendly Version
06/09/17BioTelemetry, Inc. Reaches Key Milestone in Tender Offer for LifeWatch AG
MALVERN, Pa. and ZUG, Switzerland, June 09, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that during the main offer period which ended on June 8, 2017, the preliminary results show shareholders have tendered 15,161,925 shares of LifeWatch AG (SIX:LIFE), representing approximately 82% of the total shares outstanding.     ... 
Printer Friendly Version
05/30/17LifeWatch’s Largest Shareholders Accept BioTelemetry, Inc.’s Tender Offer for LifeWatch AG
MALVERN, Pa. and ZUG, Switzerland, May 30, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that LifeWatch’s largest shareholders, including Himalaya TMT Fund, Aevis Victoria SA and Antoine Hubert, pledged support of the Company’s tender offer for all outstanding shares of LifeWatch AG (SIX:LIFE) and have agreed to tender th... 
Printer Friendly Version
05/24/17BioTelemetry, Inc. Increases Tender Offer Price and Extends Offer Period for LifeWatch AG Shares
MALVERN, Pa. and ZUG, Switzerland, May 24, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that the Company has increased the price of its previously announced public tender offer for all outstanding shares of LifeWatch AG (SIX:LIFE).  As revised, shareholders of LifeWatch will receive either CHF10.00 in cash and 0.1617 sha... 
Printer Friendly Version
05/23/17BioTelemetry, Inc. Announces Extension of the Tender Offer Period for LifeWatch AG Shares
MALVERN, Pa., May 23, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that, in accordance with the provisions of the Offer Prospectus and at the Company’s request, the Swiss Takeover Board has extended the initial main offer period of the tender offer to acquire all of the shares of LifeWatch AG (SIX:LIFE), which was schedu... 
Printer Friendly Version
05/10/17BioTelemetry, Inc. Announces the Start of the Tender Offer Period for LifeWatch AG Shares
MALVERN, Pa. and ZUG, Switzerland, May 10, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today the start of the main offer period of the tender offer to acquire all of the shares of LifeWatch AG (SIX:LIFE).  The main offer period is scheduled to expire at 4:00 p.m. CEST, on May 23, 2017.  It will be open for a period of ten tra... 
Printer Friendly Version
05/08/17BioTelemetry, Inc. Announces Receipt of Antitrust Clearance for its Acquisition of LifeWatch AG
MALVERN, Pa. and ZUG, Switzerland , May 08, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) announced today that, effective on May 5, 2017, it received early termination of the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (“HSR”) with respect to its previously announced tender offer to acquire all of the capital stock of LifeWatch AG (SIX:LIFE).  This clearance comes without any condition on or undertaking by BioTelemetry, LifeWatch or any ... 
Printer Friendly Version
05/03/17BioTelemetry, Inc. Reports First Quarter 2017 Financial Results
Company Reports Record Quarterly Revenue and Patient Volume MALVERN, Pa., May 03, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the first quarter ended March 31, 2017. Company Highlights Recognized highest quarterly revenue in Company’s history of $55.9 million, a 14.9% increase over the prior year ... 
Printer Friendly Version
04/25/17BioTelemetry, Inc. to Release First Quarter 2017 Earnings Results on May 3, 2017
MALVERN, Pa., April 25, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its first quarter 2017 earnings on Wednesday, May 3, 2017 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Wednesday, May 3, 2017.  The broadcast will be available through the investor information section of the BioTelemetry website at www.gobio.com.  If you are unable to participate during the live webcast, an archive will be available on o... 
Printer Friendly Version
04/24/17BioTelemetry, Inc. Issues Prospectus for Public Tender Offer to Acquire LifeWatch AG
LifeWatch Board of Directors Supports BioTelemetry Tender Offer MALVERN, Pa. and ZUG, Switzerland, April 24, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) and LifeWatch AG (SIX:LIFE) announced today that BioTelemetry published the prospectus for the public tender offer for all publicly held registered shares of LifeWatch AG.  Shareholders of LifeWatch will receive either CHF10.00 in cash and 0.1457 shares of BioTelemetry stock (“Main Offer Consideration”) (equivalent to CHF4.00 pe... 
Printer Friendly Version
04/09/17BioTelemetry, Inc. to Hold Investor Call on April 10, 2017
MALVERN, Pa., April 09, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will hold an investor call tomorrow, April 10, 2017 at 9:00 AM Eastern Time to discuss the recently announced transaction agreement for BioTelemetry to launch a tender offer to acquire LifeWatch AG  The broadcast will be available through the investor information section of the BioTelemetry website: www.gobio.com.  If you are unable to participate during the live webcast, an archive will be available on our we... 
Printer Friendly Version
04/09/17BioTelemetry, Inc. Launches a Tender Offer to Acquire LifeWatch AG
Strengthens Remote Patient Monitoring Platform MALVERN, Pa. and ZUG, Switzerland, April 09, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) and LifeWatch AG (SIX:LIFE) announced today that the companies have entered into a definitive transaction agreement under which BioTelemetry will launch a tender offer in Switzerland to acquire all of the outstanding shares of LifeWatch AG, with shareholders receiving either CHF10.00 in cash and 0.1457 shares of BioTelemetry stock (equivalent to... 
Printer Friendly Version
02/22/17BioTelemetry, Inc. Reports Fourth Quarter and Full Year 2016 Financial Results
Company Reports Record Results MALVERN, Pa., Feb. 22, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported results for the fourth quarter and full year ended December 31, 2016. Company Highlights Recognized highest quarterly revenue in Company’s history of $54.0 million, a 15% increase over the prior year Achieved 18... 
Printer Friendly Version
02/13/17BioTelemetry, Inc. to Release Fourth Quarter 2016 Earnings Results on February 22, 2017
MALVERN, Pa., Feb. 13, 2017 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) will release its fourth quarter 2016 earnings on Wednesday, February 22, 2017 at 4:00 PM Eastern Time. The BioTelemetry quarterly conference call will be held at 5:00 PM Eastern Time, Wednesday, February 22, 2017.  The broadcast will be available through the investor information section of the BioTelemetry website www.gobio.com.  If you are unable to participate during the live webcast, an archive will be avail... 
Printer Friendly Version
02/06/17Sprint & BioTelemetry, Inc. Receive a 2017 IoT Evolution Business Impact Award
Award Recognizes Businesses that Deployed Successful IoT Solutions OVERLAND PARK, Kan., Feb. 06, 2017 (GLOBE NEWSWIRE) -- Sprint (NYSE:S) announced today that a 2017 IoT Evolution Business Impact Award will be presented to Sprint and its client, BioTelemetry, Inc., by TMC and Crossfire Media at the IoT Evolution Conference & Expo on February 9, 2017. Sprint and BioTelemetry will present the winning case at the Expo. The Business Impact Awards program recognizes a select group of compan... 
Printer Friendly Version


Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds
Copyright © CardioNet 2002-2009, All Rights Reservedprivacy policy/termssite mapinfo@cardionet.com